TAMBE- Evaluation of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Enrolling By Invitation
18-99 years
All
Phase
N/A
30 participants needed
1 Location
Brief description of study
Normal
0
false
false
false
EN-US
JA
X-NONE
Patients with thoracoabdominal or
pararenal aneurysm disease will be asked to take part in this research study
This research
study will look at treating thoracoabdominal or pararenal aneurysm disease with
a new stent-graft design. The reason we
are doing this research study is to look at how safe the Study Device is (safety)
and how it works for your illness (usefulness). This Study Device is investigational
(experimental), which means it is has not been approved to treat your illness,
but it may be used in this study. It has not been approved by the U.S. Food and
Drug Administration (FDA / regulatory body) for yours or another type of illness.
There are
several parts to this research study. These parts are a screening visit, a surgical
procedure, and a series of follow-up clinic visits. As a part of the research study, the research team will ask that you come back to our clinic for follow-up visits.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: aneurysm,stent,graft,endoprosthesis
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
09 Sep 2024.
Study ID: 833065
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
